Advertisement

Annals of Surgical Oncology

, Volume 11, Issue 4, pp 360–361 | Cite as

The Prognostic Importance of Tumor Mitotic Rate for Patients with Primary Cutaneous Melanoma

Editorials

REFERENCES

  1. 1.
    Breslow A. Thickness, cross sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Balch CM, Buzaid AC, Soong S-J, et al. Final version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol 2001; 19: 3635–48.PubMedGoogle Scholar
  3. 3.
    Balch CM, Buzaid AC, Soong S-J, et al. New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol 2003; 21: 43–52.PubMedCrossRefGoogle Scholar
  4. 4.
    Azzola MF, Shaw HM, Thompson JF, et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma. Cancer 2003; 97: 1488–98.PubMedCrossRefGoogle Scholar
  5. 5.
    McGovern VJ, Shaw HM, Milton GW, Farago GA. Prognostic significance of the histological features of malignant melanoma. Histopathology 1979; 3: 385–93.PubMedCrossRefGoogle Scholar
  6. 6.
    Francken AB, Shaw HM, Thompson JF, et al. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol 2004; 11: 426–33.PubMedCrossRefGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 2004

Authors and Affiliations

  1. 1.Department of PathologyMemorial Sloan-Kettering Cancer CenterNew York
  2. 2.Department of PathologyMemorial Sloan-Kettering Cancer CenterNew York

Personalised recommendations